Cargando…
Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs
The impact of precision oncology on guiding treatment decisions of late-stage cancer patients was previously studied in a retrospective analysis. However, the overall survival and costs were not previously evaluated. We report the overall survival and healthcare costs associated with precision oncol...
Autores principales: | Haslem, Derrick S., Chakravarty, Ingo, Fulde, Gail, Gilbert, Heather, Tudor, Brian P., Lin, Karen, Ford, James M., Nadauld, Lincoln D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844748/ https://www.ncbi.nlm.nih.gov/pubmed/29552312 http://dx.doi.org/10.18632/oncotarget.24384 |
Ejemplares similares
-
Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2–Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine
por: Haslem, Derrick S., et al.
Publicado: (2017) -
Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs
por: Perkins, Adrienne T., et al.
Publicado: (2021) -
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
por: Haslem, Derrick S., et al.
Publicado: (2017) -
Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer
por: Xia, Li C., et al.
Publicado: (2020) -
An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer
por: Barker, Tyler, et al.
Publicado: (2020)